Genotypic Tests for Determining Coreceptor Usage of HIV-1

被引：4

作者：

Kuritzkes, Daniel R. ^{[1
,2
]}

机构：

[1] Harvard Univ, Sch Med, Boston, MA USA

[2] Brigham & Womens Hosp, Sect Retroviral Therapeut, Boston, MA 02115 USA

来源：

JOURNAL OF INFECTIOUS DISEASES | 2011年 / 203卷 / 02期

关键词：

MARAVIROC; INFECTION;

D O I：

10.1093/infdis/jiq034

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：146 / 148

页数：3

共 8 条

[1] Maraviroc versus Efavirenz, Both in Combination with Zidovudine-Lamivudine, for the Treatment of Antiretroviral-Naive Subjects with CCR5-Tropic HIV-1 Infection [J].

Cooper, David A. ;

Heera, Jayvant ;

Goodrich, James ;

Tawadrous, Margaret ;

Saag, Michael ;

DeJesus, Edwin ;

Clumeck, Nathan ;

Walmsley, Sharon ;

Ting, Naitee ;

Coakley, Eoin ;

Reeves, Jacqueline D. ;

Reyes-Teran, Gustavo ;

Westby, Mike ;

Van Der Ryst, Elna ;

Ive, Prudence ;

Mohapi, Lerato ;

Mingrone, Horacio ;

Horban, Andrzej ;

Hackman, Frances ;

Sullivan, John ;

Mayer, Howard .

JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (06) :803-813

[2] Maraviroc for previously treated patients with R5 HIV-1 infection [J].

Gulick, Roy M. ;

Lalezari, Jacob ;

Goodrich, James ;

Clumeck, Nathan ;

DeJesus, Edwin ;

Horban, Andrzej ;

Nadler, Jeffrey ;

Clotet, Bonaventura ;

Karlsson, Anders ;

Wohlfeiler, Michael ;

Montana, John B. ;

McHale, Mary ;

Sullivan, John ;

Ridgway, Caroline ;

Felstead, Steve ;

Dunne, Michael W. ;

van der Ryst, Elna ;

Mayer, Howard .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (14) :1429-U27

[3] Tropism testing in the clinical management of HIV-1 infection [J].

Lin, Nina H. ;

Kuritzkes, Daniel R. .

CURRENT OPINION IN HIV AND AIDS, 2009, 4 (06) :481-487

[4] A Double-Blind, Placebo-Controlled Trial of Maraviroc in Treatment-Experienced Patients Infected with Non-R5 HIV-1 [J].

Saag, Michael ;

Goodrich, James ;

Faetkenheuer, Gerd ;

Clotet, Bonaventura ;

Clumeck, Nathan ;

Sullivan, John ;

Westby, Mike ;

van der Ryst, Elna ;

Mayer, Howard .

JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (11) :1638-1647

[5] Response to Vicriviroc in Treatment-Experienced Subjects, as Determined by an Enhanced-Sensitivity Coreceptor Tropism Assay: Reanalysis of AIDS Clinical Trials Group A5211 [J].

Su, Zhaohui ;

Gulick, Roy M. ;

Krambrink, Amy ;

Coakley, Eoin ;

Hughes, Michael D. ;

Han, Dong ;

Flexner, Charles ;

Wilkin, Timothy J. ;

Skolnik, Paul R. ;

Greaves, Wayne L. ;

Kuritzkes, Daniel R. ;

Reeves, Jacqueline D. .

JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (11) :1724-1728

[6]

SWENSON LC, 2010, J INFECT DIS, DOI DOI 10.1093/JID/JIQ030

[7] Quantitative Deep Sequencing Reveals Dynamic HIV-1 Escape and Large Population Shifts during CCR5 Antagonist Therapy In Vivo [J].

Tsibris, Athe M. N. ;

Korber, Bette ;

Arnaout, Ramy ;

Russ, Carsten ;

Lo, Chien-Chi ;

Leitner, Thomas ;

Gaschen, Brian ;

Theiler, James ;

Paredes, Roger ;

Su, Zhaohui ;

Hughes, Michael D. ;

Gulick, Roy M. ;

Greaves, Wayne ;

Coakley, Eoin ;

Flexner, Charles ;

Nusbaum, Chad ;

Kuritzkes, Daniel R. .

PLOS ONE, 2009, 4 (05)

[8] Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism [J].

Whitcomb, Jeannette M. ;

Huang, Wei ;

Fransen, Signe ;

Limoli, Kay ;

Toma, Jonathan ;

Wrin, Terri ;

Chappey, Colombe ;

Kiss, Linda D. B. ;

Paxinos, Ellen E. ;

Petropoulos, Christos J. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (02) :566-575

← 1 →